Your browser doesn't support javascript.
loading
Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study.
Wang, Qun; Zhong, Yan-Jun; Yuan, Jing-Ping; Shao, Li-Hua; Zhang, Jue; Tang, Li; Liu, Shao-Ping; Hong, Ya-Ping; Firestone, Raymond A; Li, Yan.
Affiliation
  • Wang Q; Department of Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, No 169 Donghu Road, Wuchang District, 430071 Wuhan, P,R, China. liyansd2@163.com.
J Transl Med ; 11: 192, 2013 Aug 21.
Article in En | MEDLINE | ID: mdl-23961994

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Prodrugs / Doxorubicin / Carcinoma, Hepatocellular / Liver Neoplasms / Lung Neoplasms Type of study: Clinical_trials Limits: Animals / Humans / Male Language: En Journal: J Transl Med Year: 2013 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Prodrugs / Doxorubicin / Carcinoma, Hepatocellular / Liver Neoplasms / Lung Neoplasms Type of study: Clinical_trials Limits: Animals / Humans / Male Language: En Journal: J Transl Med Year: 2013 Document type: Article Affiliation country: China Country of publication: United kingdom